Wednesday, August 15, 2018 2:44:49 PM
As reflected in the accompanying financial statements, the Company’s working capital deficit for the period ended June 30, 2018, was
$2,402,537 and the Company’s balance sheet reflects a net stockholders’ deficit of $17,782,224. The Company’s ability to continue operating
as a “going concern” is dependent on its ability to increase revenues and raise additional working capital. These matters raise substantial doubt
about the Company’s ability to continue as a going concern. The financial statements have been prepared on a going concern basis, which
contemplates realization of assets and liquidation of liabilities in the ordinary course of business. The Company plans to raise additional capital
as needed. There can be no assurance that this capital will be available and if it is not, the Company may be forced to substantially curtail or
cease operations. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.
Well this sounds very promising.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM